abrdn plc Purchases New Holdings in Tarsus Pharmaceuticals,

abrdn plc acquired a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 72,032 shares of the company’s stock, valued at approximately $1,459,000. abrdn plc owned approximately 0.22% of Tarsus Pharmaceuticals as of […]

Related Keywords

China , United States , Bobakr Azamian , Aziz Mottiwala , Zurcher Kantonalbank Zurich Cantonalbank , Tarsus Pharmaceuticals Inc , Tarsus Pharmaceuticals Company Profile , Securities Exchange Commission , Mirae Asset Global Investments Co , Tarsus Pharmaceuticals Stock , Quarter For Tarsus Pharmaceuticals , News Ratings For Tarsus Pharmaceuticals Daily , Raymond James Associates , Tarsus Pharmaceuticals , Goldman Sachs Group , Ieq Capital , Exchange Commission , Jefferies Financial Group , China Universal Asset Management Co , Barclays , Nasdaq , Free Report , Universal Asset Management , Kantonalbank Zurich Cantonalbank , Mirae Asset Global Investments , Get Free Report , Financial Group , Tarsus Pharmaceuticals Daily , Nasdaq Tars , Stars , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,